NCT04160676View on ClinicalTrials.gov

Therapy With Hydrocortisone, Ascorbic Acid, Thamine in Patients With Sepsis

NACompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

December 1, 2019

Primary Completion Date

July 26, 2021

Study Completion Date

July 26, 2021

Conditions
Sepsis
Interventions
DRUG

Hydrocortisone, Ascorbic acid, Thiamine

Combination of hydrocortisone, ascorbic acid, and thiamine

DRUG

Normal saline

Normal saline

Trial Locations (1)

31511

Tanta University hospitals, Tanta

All Listed Sponsors
collaborator

Mostafa Ismail Sharaf

UNKNOWN

collaborator

Salah Eldeen Ibrahim Alsherif

UNKNOWN

collaborator

Mohamed Mohi El deen Abo El yazeed

UNKNOWN

lead

Tanta University

OTHER

NCT04160676 - Therapy With Hydrocortisone, Ascorbic Acid, Thamine in Patients With Sepsis | Biotech Hunter | Biotech Hunter